Skip to search formSkip to main contentSkip to account menu

umirolimus

Known as: 40-O-(2-ethoxyethyl)rapamycin, 42-O-(2-ethoxyethyl) rapamycin, rapamycin, 42-O-(2-ethoxyethyl)- 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (3)

Anti-Inflammatory AgentsImmunosuppressive AgentsSirolimus

Narrower (1)

Biolimus A9
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2020
Highly Cited
2020
Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk.
BACKGROUND Polymer-free drug-coated stents provide superior clinical outcomes to bare-metal stents in patients at high bleeding… 
2017
2017
Comparison of Biolimus Versus Everolimus for Drug-Eluting Stents in the Percutaneous Treatment of Infra-Inguinal Arterial Disease.
BACKGROUND Drug-eluting stents (DES) are now considered the most promising device to treat peripheral artery disease (PAD) and… 
2016
2016
Bare metal stenty na cestě dinosaurů: studie LEADERS FREE
Randomizovana, dvojitě zaslepena studie srovnala použiti kovoveho (BMS) a bezpolymeroveho lekoveho stentu (DES) při lecbě nemocn… 
Highly Cited
2015
Highly Cited
2015
Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk.
BACKGROUND Patients at high risk for bleeding who undergo percutaneous coronary intervention (PCI) often receive bare-metal… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)